Servier – Charm – Daily News

Insilico Medicine advances Middle East push with UAE AI drug discovery deal

7 months ago02 mins

Hong Kong-listed Insilico Medicine has signed a cooperation agreement with the United Arab Emirates’ drug regulator to advance the use of its artificial intelligence tools in drug discovery across the region, even as geopolitical tensions escalate in the Middle East. Shares of Insilico rose as much as 12.8 per cent in morning trading on Thursday…

Insilico signs US$888 million AI drug-development deal days after Hong Kong IPO

9 months ago02 mins

The deal comes just days after the US company’s shares debuted following its initial public offering (IPO), which raised HK$2.28 billion (US$293 million) after the public portion was oversubscribed 1,427 times. The multi-year partnership with Servier, unveiled on Saturday, would make Insilico eligible for up to US$32 million in upfront and near-term research and development…